Myriad Genetics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
Stocks For You To Swing-Trade: MS, MYGN, BAC
Article By: Ryan Mallory
Friday, March 22, 2019 6:55 AM EDT
Take a look at three trading ideas to prep you for the next trading session.
In this article: BAC, MS, MYGN
Read
Myriad Genetics' EndoPredict Gets Positive Coverage Decision
Article By: Zacks Investment Research
Friday, August 18, 2017 5:21 PM EDT
For the past three months, Myriad Genetics has been trading above the broader industry. The stock has gained 32.2%, higher than the industry’s gain of 4.5%.
In this article: MYGN Also: ALGN, IDXX, LNTH
Read
FDA OKs Tesaro’s "Niraparib" For Ovarian Cancer - Major Setback For Myriad Genetics Inc
Article By: Lorimer Wilson
Tuesday, March 28, 2017 11:10 AM EDT
Tesaro, Inc. has been given a broad approval by the FDA for the use of its PARP drug niraparib, which will now be marketed as Zejula as a maintenance therapy for recurrent ovarian cancer which represents a major setback for Myriad Genetics, Inc.
In this article: TSRO, MYGN Also: AZN, CLVS
Read
PlasmaTech Announces Reverse Stock Split, Launches New Corporate Website; CEL-SCI Announces Closing Of Public Offering
Article By: BioMedReports
Sunday, October 26, 2014 6:36 PM EDT
BioMed Reports takes a look at some of the headlines for companies that made news in the healthcare sector this week...
In this article: CVM, ACCP, SIMH, RDNT, TNDM, ACET, CUTR, MYGN, QLTI, ZFGN, HIIQ, HQY, ALDR, MCIG, OXFD, PINC
Read
Active Stocks: TTPH, RPRX, HZNP, THRX, MYGN
Article By: BioMedReports
Friday, October 17, 2014 5:12 PM EDT
U.S. stocks rallied Friday, extending a string of sharp moves, amid upbeat economic news from the U.S. and rising hopes for more stimulus from global central banks.
In this article: RPRX, THRX, HZNP, MYGN, TTPH
Read

PARTNER HEADLINES

Latest Tweets for $MYGN

No tweets yet!